Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2022 May 7

PMID 35525908

Authors

Liyuan Zhu

Kui Liu

Qi Feng

Yingnan Liao

Affiliations

Soon will be listed here.

Abstract

Cardiac organoids (COs) are miniaturized and simplified organ structures that can be used in heart development biology, drug screening, disease modeling, and regenerative medicine. This cardiac organoid (CO) model is revolutionizing our perspective on answering major cardiac physiology and pathology issues. Recently, many research groups have reported various methods for modeling the heart in vitro. However, there are differences in methodologies and concepts. In this review, we discuss the recent advances in cardiac organoid technologies derived from human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs), with a focus on the summary of methods for organoid generation. In addition, we introduce CO applications in modeling heart development and cardiovascular diseases and discuss the prospects for and common challenges of CO that still need to be addressed. A detailed understanding of the development of CO will help us design better methods, explore and expand its application in the cardiovascular field.

Citing Articles

Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.

Wang Y, Hou Y, Hao T, Garcia-Contreras M, Li G, Cretoiu D Biomater Transl. 2025; 5(4):337-354.

PMID: 39872935 PMC: 11764187. DOI: 10.12336/biomatertransl.2024.04.002.

Revolutionizing cardiovascular research: Human organoids as a Beacon of hope for understanding and treating cardiovascular diseases.

Li J, Li Y, Song G, Wang H, Zhang Q, Wang M Mater Today Bio. 2025; 30():101396.

PMID: 39802826 PMC: 11719415. DOI: 10.1016/j.mtbio.2024.101396.

Small extracellular vesicles derived from umbilical cord mesenchymal stem cells alleviate radiation-induced cardiac organoid injury.

Cao H, Yue L, Shao J, Kong F, Liu S, Huai H Stem Cell Res Ther. 2024; 15(1):493.

PMID: 39707562 PMC: 11662859. DOI: 10.1186/s13287-024-04115-2.

Progress in the Application of Organoids-On-A-Chip in Diseases.

Geng Q, Xu Y, Hu Y, Wang L, Wang Y, Fan Z Organogenesis. 2024; 20(1):2386727.

PMID: 39126669 PMC: 11318694. DOI: 10.1080/15476278.2024.2386727.

Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development.

Chi C, Roland T, Song K Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543122 PMC: 10975450. DOI: 10.3390/ph17030337.

References

Zwi-Dantsis L, Gepstein L . Induced pluripotent stem cells for cardiac repair. Cell Mol Life Sci. 2012; 69(19):3285-99. PMC: 11114685. DOI: 10.1007/s00018-012-1078-2. View

Kim J, Koo B, Knoblich J . Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020; 21(10):571-584. PMC: 7339799. DOI: 10.1038/s41580-020-0259-3. View

McCauley H, Wells J . Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish. Development. 2017; 144(6):958-962. PMC: 5358106. DOI: 10.1242/dev.140731. View

Voges H, Mills R, Elliott D, Parton R, Porrello E, Hudson J . Development of a human cardiac organoid injury model reveals innate regenerative potential. Development. 2017; 144(6):1118-1127. DOI: 10.1242/dev.143966. View

Fatehullah A, Tan S, Barker N . Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016; 18(3):246-54. DOI: 10.1038/ncb3312. View

Correia C, Koshkin A, Duarte P, Hu D, Carido M, Sebastiao M . 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes. Biotechnol Bioeng. 2017; 115(3):630-644. DOI: 10.1002/bit.26504. View

Chen V, Ye J, Shukla P, Hua G, Chen D, Lin Z . Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res. 2015; 15(2):365-75. PMC: 4600677. DOI: 10.1016/j.scr.2015.08.002. View

Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R . Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc. 2015; 10(9):1345-61. DOI: 10.1038/nprot.2015.089. View

Domian I, Chiravuri M, van der Meer P, Feinberg A, Shi X, Shao Y . Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science. 2009; 326(5951):426-9. PMC: 2895998. DOI: 10.1126/science.1177350. View

10.

Kattman S, Witty A, Gagliardi M, Dubois N, Niapour M, Hotta A . Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8(2):228-40. DOI: 10.1016/j.stem.2010.12.008. View

11.

Eschenhagen T, Zimmermann W . Engineering myocardial tissue. Circ Res. 2005; 97(12):1220-31. DOI: 10.1161/01.RES.0000196562.73231.7d. View

12.

Beauchamp P, Moritz W, Kelm J, Ullrich N, Agarkova I, Anson B . Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes. Tissue Eng Part C Methods. 2015; 21(8):852-61. DOI: 10.1089/ten.TEC.2014.0376. View

13.

Daly A, Davidson M, Burdick J . 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. Nat Commun. 2021; 12(1):753. PMC: 7854667. DOI: 10.1038/s41467-021-21029-2. View

14.

Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden R . Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020; 26(6):862-879.e11. PMC: 7284308. DOI: 10.1016/j.stem.2020.05.004. View

15.

Beauchamp P, Jackson C, Ozhathil L, Agarkova I, Galindo C, Sawyer D . 3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids. Front Mol Biosci. 2020; 7:14. PMC: 7033479. DOI: 10.3389/fmolb.2020.00014. View

16.

Zuppinger C . Measurement of Contractility and Calcium Release in Cardiac Spheroids. Methods Mol Biol. 2019; 1929:41-52. DOI: 10.1007/978-1-4939-9030-6_4. View

17.

Arai K, Murata D, Verissimo A, Mukae Y, Itoh M, Nakamura A . Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printer. PLoS One. 2018; 13(12):e0209162. PMC: 6296519. DOI: 10.1371/journal.pone.0209162. View

18.

Ong C, Pitaktong I, Hibino N . Principles of Spheroid Preparation for Creation of 3D Cardiac Tissue Using Biomaterial-Free Bioprinting. Methods Mol Biol. 2020; 2140:183-197. DOI: 10.1007/978-1-0716-0520-2_12. View

19.

Pitaktong I, Lui C, Lowenthal J, Mattson G, Jung W, Bai Y . Early Vascular Cells Improve Microvascularization Within 3D Cardiac Spheroids. Tissue Eng Part C Methods. 2019; 26(2):80-90. PMC: 8884142. DOI: 10.1089/ten.TEC.2019.0228. View

20.

Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib I . Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res. 2007; 100(2):263-72. DOI: 10.1161/01.RES.0000257776.05673.ff. View